Indaptus Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Indaptus Therapeutics

14/03/2024 14:02

* Indaptus Therapeutics Inc  INDP.OQ  reported a quarterly
adjusted loss of 48 cents​​ per share for the quarter ended in
December, lower than the same quarter last year, when the
company reported EPS of -44 cents.  The mean expectation of
two analysts for the quarter was for a loss of 54 cents per
share. 
    * Reported revenue was zero​; analysts expected zero. 
    * Indaptus Therapeutics Inc's reported EPS for the quarter
was a
loss of 48 cents​.
    * The company reported a quarterly loss of $4 million.
    * Indaptus Therapeutics Inc shares had risen by 13.6% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Indaptus
Therapeutics Inc is $10.00 

This summary was machine generated from LSEG data March 14 at
02:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.54          -0.48          Beat
 Sep. 30 2023      -0.55          -0.47          Beat
 Jun. 30 2023      -0.58          -0.39          Beat
 Mar. 31 2023      -0.59          -0.51          Beat